Summary
The study investigated the respective influences of nicotinic acid and somatostatin on plasma concentrations of blood glucose, free fatty acids, glucagon, growth hormone and cortisol in insulin-dependent diabetic subjects. After administration of nicotinic acid alone, marked depression of plasma FFA was accompanied by significant increases of plasma glucagon, growth hormone and cortisol. The glucagon and growth hormone responses to nicotinic acid were significantly reduced when plasma FFA were raised by intravenous administration of heparin and triglycerides. Somatostatin alone induced a significant decrease in blood glucose, plasma glucagon and growth hormone concentrations. Plasma FFA remained unchanged. Somatostatin did not modify the nicotinic acid-induced fall in plasma FFA, but completely blocked the corresponding increments in glucagon and growth hormone. The cortisol rise was not altered by somatostatin. Rebound of glucagon and growth hormone levels were seen upon discontinuation of the somatostatin administration. These results demonstrate that the plasma FFA concentration plays a role in the regulation of glucagon and growth hormone secretion in insulin-dependent diabetics. Furthermore, they indicate that somatostatin, previously shown to be capable of negating the stimulatory effect of various factors on glucagon and growth hormone secretion, also affects the response of these hormones to FFA depression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alford, F. P., Bloom, S. R., Nabarro, J. D. N., Hall, R., Besser, G. M., Coy, D. H., Kastin, A. J., Schally, A. V.: Glucagon control of fasting glucose in man. Lancet1974 II, 974–976
Andrews, S. S., Lopez, S. A., Blackard, W. G.: Effect of lipids on glucagon secretion in man. Metabolism24, 35–44 (1975)
Assan, R., Basdevant, A., Heuclin, C, Selmi, A., Husson, J. C., Girard, J. R.: Effect on circulating hormones and fuels of acute somatostatin administration in insulin-dependent diabetic patients. (In preparation)
Bryce, D. B. S., Yeh, M., Funderburk, C., Todd, H., Hertelendy, F.: Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Diabetes24, 842–850 (1975)
Chideckel, E. W., Palmer, J., Koerker, D. J., Ensinck, J., Davidson, M. B., Goodner, C. J.: Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis. J. clin. Invest.55, 754–762 (1975)
Christensen, S. E., Hansen, A. A. P., Iversen, J., Lundbaek, K., Orskov, H., Seyer-Hansen, K.: Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: Modifications of glucagon and insulin release. Scand. J. clin. Lab. Invest.34, 321–325 (1974)
Dole, V. P., Meinertz, H.: Microdetermination of long chain fatty acids in plasma and tissues. J. biol. Chem.235, 2595–2599 (1960)
Franchimont, P., Burger, H.: Human growth hormone and gonadotrophins in health and disease. Amsterdam: North-Holland Publishing Company, New York: Oxford and American Elsevier Publishing Company Inc. 1975
Gerich, J. E., Lorenzi, M., Hane, S., Gustafson, G., Guillemin, R., Forsham, P. H.: Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: Studies with somatostatin. Metabolism24, 175–182 (1975)
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R., Forsham, P. H.: Effect of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. New Engl. J. Med.291, 544–547 (1974)
Gerich, J. E., Lorenzi, M., Schneider, V., Kwan, C. W., Karam, J. H., Guillemin, R., Forsham, P. H.: Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes23, 876–880 (1974)
Gerich, J. E., Langlois, M., Schneider, V., Karam, J. H., Noacco, C.: Effects of alterations of plasma free fatty acid levels on pancreatic glucagon secretion in man. J. clin. Invest.53, 1284–1289 (1974)
Hall, R., Schally, A. V., Evered, D., Kastin, A. J., Mortimer, C. H., Tunbridge, W. M. G., Besser, G. M., Coy, D. H., Goldie, D. J., Mc Neilly, A. S., Phenekos, C. C., Wightman, D.: Action of growth hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet1973 II 581–584
Hansen, A. P., Orskov, H., Seyer-Hansen, K., Lundbaek, K.: Some actions of growth hormone release inhibiting factor. Brit. med. J.1973 III, 523–524
Hoffman, W. S.: A rapid photoelectric method for determination of glucose in blood and urine. J. biol. Chem.120, 51–55 (1937)
Johnson, W. J.: Stimulation of adrenocortical secretion by nicotinic acid and certain of its derivatives and analogues. Biochem. med.2, 438–447 (1969)
Kagedal, B., Laurell, S., Rerup, C., Thorell, J.: Effect of nicotinic-acid-induced variation of plasma free fatty acids on some hormones in starving subjects. Scand. J. clin. Invest.31, 331–336 (1973)
Leclercq, R.: Le dosage par compétition du cortisol plasmatique. Rev. Franç. Etud. clin. Biol.14, 815–819 (1969)
Lorenzi, M., Karam, J. H., Schneider, V., Gustafson, G., Horita, S., Gerich, J. E.: Effect of somatostatin on plasma glucose, free fatty acids and glucagon responses to epinephrine in human diabetes. Clin. Res.23 (Abstr.), 112A, (1975)
Lovinger, R., Boryczka, A. T., Shackelford, R., Kaplan, S. L., Ganong, W. F., Grumbach, M. M.: Effect of synthetic somatotropin release inhibiting factor on the increase in plasma growth hormone elicited by L-Dopa in the dog. Endocrinology95, 943–946 (1974)
Luft, R., Guillemin, R.: Growth hormone and diabetes in man. Diabetes23, 783–787 (1974)
Luyckx, A. S.: Immunoassays for glucagon. In: Glucagon. Molecular physiology, clinical and therapeutic implications. (eds. P. J. Lefebvre, R. H. Unger, pp. 285–298. Oxford: Pergamon Press 1972
Luyckx, A. S., Lefebvre, P. J.: Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc. Soc. exp. Biol. (N. Y.)133, 524–528 (1970)
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L. Coy, D. H., Kastin, A., Besser, G. M., Hall, R.: Effects of growth hormone release inhibiting hormone on circulating glucagon, insulin and growth hormone in normal, diabetic, acromegalic and hypopituitary patients. Lancet1974 I, 697–701
Ohneda, A., Ishii, S., Horigome, K., Yamagata, S.: Glucagon response to arginine after treatment of diabetes mellitus. Diabetes24, 811–819 (1975)
Peracchi, M., Reschini, E., Cantalamessa, L., Giustina, G., Cavagnini, M., Pinto, M., Bulgheroni, P.: Effect of somatostatin on blood glucose, plasma growth hormone, insulin and free fatty acids in normal subjects and acromegalic patients. Metabolism23, 1009–1015 (1974)
Quabbe, H. J., Ramek, W., L'Age, M., Luyckx, A. S.: Hormonal response to depression of free fatty acids (hGH, cortisol, insulin, glucagon) and the effect of glucose infusion. (Submitted to J. clin. Endocr.)
Sakurai, H., Dobbs, R., Unger, R. H.: Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs. J. clin. Invest.54, 1395–1402 (1974)
Schade, D. S., Eaton, R. P.: Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics. Diabetes24, 510–515 (1975)
Siler, T. M., Vandenberg, G., Yen, S. S. C., Brazeau, P., Vale, W., Guillemin, R.: Inhibition of growth hormone release in humans by somatostatin. J. clin. Endocr.37, 632–634 (1973)
Snedecor, G. W.: Statistical methods. 5th edition. Ames, Iowa: The Iowa State University Press 1966
Unger, R. H., Orci, L.: The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet1975 I, 14–16
Weir, G. C., Knowlton, S. D., Martin, D. B.: Somatostatin inhibition of epinephrine-induced glucagon secretion. Endocrinology95, 1744–1746 (1974)
Yen, S. S. C., Siler, T. M., Devane, G. W.: Effect of somatostatin in patients with acromegaly. Suppression of growth hormone, prolactin, insulin and glucose levels. New Engl. J. med.290, 935–938 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luyckx, A.S., Lefebvre, P.J. Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics. Diabetologia 12, 447–453 (1976). https://doi.org/10.1007/BF01219508
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219508